Marinus Verwijs serves as Executive at Aerovate Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Marinus Verwijs has executed 12 insider transactions totaling $646.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 14, 2024 involved exercising options for 10,600 shares valued at $154.7K.
Marinus Verwijs currently holds 10,600 shares of Aerovate Therapeutics, Inc. (AVTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marinus Verwijs has been a net seller of AVTE stock. They have purchased $0 and sold $646.9K worth of shares.
Marinus Verwijs's most recent insider trade was on Jun 14, 2024, when they sold 10,600 shares at $14.59 per share.
Get notified when new Form 4 filings are submitted
| $25.00 |
| Planned |
| May 2, 2024 | AVTE | $41.6K | Sale | 1,981 | $21.02 | Discretionary |
| Apr 1, 2024 | AVTE | $77.3K | Option Exercise | 5,300 | $14.59 | Planned |
| Apr 1, 2024 | AVTE | $45.1K | Sale | 1,504 | $30.00 | Planned |
| Apr 1, 2024 | AVTE | $109.6K | Sale | 3,796 | $28.87 | Planned |
| Mar 19, 2024 | AVTE | $73.1K | Sale | 2,764 | $26.46 | Planned |
| Mar 19, 2024 | AVTE | $77.3K | Option Exercise | 5,300 | $14.59 | Planned |
| Mar 19, 2024 | AVTE | $65.1K | Sale | 2,536 | $25.68 | Planned |
| Nov 1, 2023 | AVTE | $10.1K | Sale | 970 | $10.46 | Discretionary |
| May 3, 2023 | AVTE | $15.8K | Sale | 759 | $20.79 | Discretionary |
| Nov 2, 2022 | AVTE | $21.3K | Sale | 1,130 | $18.89 | Discretionary |